Phathom Pharmaceuticals, Inc. Form SCHEDULE 13D/A — Nov 2, 2026
Frazier Life Sciences entities, along with principals James N. Topper and Patrick J. Heron, filed Amendment No. 12 to their Schedule 13D on Phathom Pharmaceuticals, updating beneficial ownership as of October 29, 2026.
Key figures
- Fls x shares
- 59403
- Flspf shares
- 5323356
- Heron shares
- 5901756
- Fls ix shares
- 5827415
- Fls xi shares
- 980286
- Flspf percent
- 6.5%
- Heron percent
- 7.3%
- Topper shares
- 6013327
- Fls ix percent
- 7.2%
- Fls xii shares
- 276029
- Topper percent
- 7.4%
- Warrants 9 99 limit
- 2,608,922 shares (FLSPF 2,596,399; FLS XI 12,523)
- Warrants 19 99 limit
- 1,250,078 shares (FLSPF 1,109,569; FLS XI 10,376; FLS XII 130,133)
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.